State Of New Jersey Common Pension Fund D Apellis Pharmaceuticals, Inc. Transaction History

State Of New Jersey Common Pension Fund D

$23.8 Billion
Q3 2024

A detailed history of State Of New Jersey Common Pension Fund D transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 49,795 shares of APLS stock, worth $1.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

49,795

Previous 45,241 10.07%

Holding current value

$1.69 Million

Previous $1.74 Million 17.23%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$28.84 - $41.15 $131,337 - $187,397	4,554 Added 10.07%	49,795 $1.44 Million
Q2 2024 Aug 07, 2024	BUY	$38.07 - $59.71 $107,357 - $168,382	2,820 Added 6.65%	45,241 $1.74 Million
Q1 2024 May 02, 2024	SELL	$55.39 - $72.47 $589,515 - $771,298	-10,643 Reduced 20.06%	42,421 $2.49 Million
Q4 2023 Feb 02, 2024	SELL	$37.14 - $64.82 $314,092 - $548,182	-8,457 Reduced 13.75%	53,064 $3.18 Million
Q3 2023 Nov 08, 2023	BUY	$23.65 - $89.22 $244,257 - $921,464	10,328 Added 20.17%	61,521 $2.34 Million
Q2 2023 Aug 02, 2023	SELL	$76.68 - $93.31 $299,205 - $364,095	-3,902 Reduced 7.08%	51,193 $4.66 Million
Q1 2023 Apr 26, 2023	SELL	$46.59 - $66.96 $130,824 - $188,023	-2,808 Reduced 4.85%	55,095 $3.63 Million
Q4 2022 Feb 01, 2023	BUY	$43.24 - $61.04 $132,703 - $187,331	3,069 Added 5.6%	57,903 $2.99 Million
Q3 2022 Oct 28, 2022	BUY	$44.76 - $69.66 $178,637 - $278,013	3,991 Added 7.85%	54,834 $3.75 Million
Q2 2022 Aug 04, 2022	SELL	$35.07 - $59.21 $293,991 - $496,357	-8,383 Reduced 14.15%	50,843 $2.3 Million
Q1 2022 May 03, 2022	SELL	$35.46 - $54.12 $166,945 - $254,796	-4,708 Reduced 7.36%	59,226 $3.01 Million
Q4 2021 Jan 31, 2022	BUY	$30.74 - $49.16 $622,485 - $995,489	20,250 Added 46.36%	63,934 $3.02 Million
Q3 2021 Oct 27, 2021	SELL	$31.4 - $69.84 $149,872 - $333,346	-4,773 Reduced 9.85%	43,684 $1.44 Million
Q2 2021 Jul 23, 2021	SELL	$40.9 - $64.9 $77,791 - $123,439	-1,902 Reduced 3.78%	48,457 $3.06 Million
Q1 2021 Apr 27, 2021	SELL	$40.8 - $57.39 $530,114 - $745,668	-12,993 Reduced 20.51%	50,359 $2.16 Million
Q4 2020 Feb 03, 2021	SELL	$30.79 - $57.2 $612,351 - $1.14 Million	-19,888 Reduced 23.89%	63,352 $3.62 Million
Q3 2020 Oct 27, 2020	BUY	$25.89 - $33.65 $586,926 - $762,845	22,670 Added 37.43%	83,240 $2.51 Million
Q2 2020 Aug 04, 2020	SELL	$24.8 - $38.49 $424,898 - $659,449	-17,133 Reduced 22.05%	60,570 $1.98 Million
Q4 2019 Jan 31, 2020	SELL	$22.1 - $30.8 $141,373 - $197,027	-6,397 Reduced 7.61%	77,703 $2.38 Million
Q3 2019 Oct 23, 2019	BUY	$24.09 - $32.18 $2.03 Million - $2.71 Million	84,100 New	84,100 $2.03 Million

Others Institutions Holding APLS

# of Institutions

309

Shares Held

115M

Call Options Held

3.85M

Put Options Held

1.09M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.73B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.

Account

State Of New Jersey Common Pension Fund D Apellis Pharmaceuticals, Inc. Transaction History